🔎 Trials Near Me

Home › Phenylketonuria › Texas

Phenylketonuria clinical trials in Texas

7 studies for Phenylketonuria are looking for participants at sites in Texas.

Cities in Texas

A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With Phenylketonuria

  • University of Texas Southwestern Medical Center (UTSW), Dallas
RecruitingPhase 1
Ages 18 to 69 · All sexes · Updated Sep 28, 2026 · NCT07241234

AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)

  • University or Texas, Southwestern medical Center, Dallas
RecruitingPhase 1/2
Ages 18 to 55 · All sexes · Updated Aug 18, 2026 · NCT06332807

A Study of JNT-517 in Participants With Phenylketonuria (PKU)

  • University of Texas Southwestern, Dallas
  • University of Texas Health (UTHealth) Science Center at Houston, Houston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 8, 2026 · NCT06971731

Immune Modulation During Palynziq® Treatment in Adults (IMPALA)

  • UT Southwestern Medical Center, Dallas
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated Jun 17, 2026 · NCT07477691

A Long-Term Study of JNT-517 in Participants With Phenylketonuria

  • Children's Medical Center Dallas, Dallas
  • University of Texas Southwestern Medical Center, Dallas
  • University of Texas Health (UTHealth) Science Center at Houston, Houston
RecruitingPhase 3
Ages 4 and older · All sexes · Updated May 1, 2026 · NCT06628128

A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)

  • University of Texas Southwestern Medical Center, Dallas
RecruitingObservational study
All ages · All sexes · Updated Mar 25, 2026 · NCT05813678

A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)

  • UT Southwestern Medical Center, Dallas
RecruitingObservational study
All ages · All sexes · Updated Mar 24, 2026 · NCT06305234

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.